Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hisanori Takenobu
Observed names:
H Takenobu,
HISANORI TAKENOBU,
Takenobu, Hisanori
Institution:
Research Institute for Clinical Oncology, Saitama Cancer Center
Observed institutions:
Chiba Cancer Center,
Saitama Cancer Center,
Chiba Cancer Center Research Institute,
Research Institute for Clinical Oncology, Saitama Cancer Center,
Research Institute for Microbial Diseases, The University of Osaka,
Saitama University,
The University of Osaka
show all 7
ORCID:
0000-0001-7355-1565
Observed ORCID:
0000-0001-7355-1565
OpenAlex ID:
A5049696172
Works
36
Awards
6
CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
2010
·
H Takenobu
, O Shimozato
, et al.
·
Oncogene
·
129
Bmi1 is a MYCN target gene that regulates tumorigenesis through repression of KIF1B β and TSLC1 in neuroblastoma
2010
·
H Ochiai
, H Takenobu
, et al.
·
Oncogene
·
85
EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications
2018
·
Zhenghao Li
, Hisanori Takenobu
, et al.
·
Oncogene
·
81
PDF
The secreted form of the p40 subunit of interleukin (IL)‐12 inhibits IL‐23 functions and abrogates IL‐23‐mediated antitumour effects
2005
·
Osamu Shimozato
, Shin‐ichi Ugai
, et al.
·
Immunology
·
81
PDF
The Stress- and Inflammatory Cytokine-induced Ectodomain Shedding of Heparin-binding Epidermal Growth Factor-like Growth Factor Is Mediated by p38 MAPK, Distinct from the 12-O-Tetradecanoylphorbol-13-acetate- and Lysophosphatidic Acid-induced Signaling Cascades
2003
·
Hisanori Takenobu
, Ayano Yamazaki
, et al.
·
Journal of Biological Chemistry
·
73
PDF
Receptor-type protein tyrosine phosphatase κ directly dephosphorylates CD133 and regulates downstream AKT activation
2014
·
O Shimozato
, M Waraya
, et al.
·
Oncogene
·
50
N-MYC promotes cell proliferation through a direct transactivation of neuronal leucine-rich repeat protein-1 (NLRR1) gene in neuroblastoma
2008
·
M S Hossain
, T Ozaki
, et al.
·
Oncogene
·
50
Plk1 regulates liver tumor cell death by phosphorylation of TAp63
2009
·
S Komatsu
, H Takenobu
, et al.
·
Oncogene
·
37
Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells
2005
·
Ling Yu
, Hisanori Takenobu
, et al.
·
Oncology Reports
·
31
Bmi1 regulates cell fate via tumor suppressor WWOX repression in small‐cell lung cancer cells
2011
·
Masaki Kimura
, Hisanori Takenobu
, et al.
·
Cancer Science
·
30
PDF
Loss of p53 suppresses replication stress-induced DNA damage in ATRX-deficient neuroblastoma
2021
·
Jesmin Akter
, Yutaka Katai
, et al.
·
Oncogenesis
·
29
PDF
Polycomb group molecule PHC3 regulates polycomb complex composition and prognosis of osteosarcoma
2010
·
Shintaro Iwata
, Hisanori Takenobu
, et al.
·
Cancer Science
·
25
PDF
Platelet-to-Lymphocyte Ratio Predicts the Efficacy of Pembrolizumab in Patients With Urothelial Carcinoma
2022
·
RYO KURASHINA
, KIYOHIRO ANDO
, et al.
·
Anticancer Research
·
21
ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors
2023
·
Sultana Parvin
, Jesmin Akter
, et al.
·
BMC Cancer
·
15
PDF
Novel 1p tumour suppressor Dnmt1-associated protein 1 regulates MYCN/ataxia telangiectasia mutated/p53 pathway
2014
·
Yohko Yamaguchi
, Hisanori Takenobu
, et al.
·
European Journal of Cancer
·
13
Pretreatment Hemoglobin Levels and Platelet-to-Lymphocyte Ratio Predict Survival Benefit from Pembrolizumab in Advanced Urothelial Carcinoma
2023
·
RYO KURASHINA
, KIYOHIRO ANDO
, et al.
·
Cancer Diagnosis & Prognosis
·
12
PDF
Development of an osteosarcoma model with MYCN amplification and TP53 mutation in hiPS cell‐derived neural crest cells
2023
·
Kyosuke Mukae
, Hisanori Takenobu
, et al.
·
Cancer Science
·
10
PDF
Polycomb EZH1 regulates cell cycle/5‐fluorouracil sensitivity of neuroblastoma cells in concert with MYCN
2022
·
Yoshitaka Shinno
, Hisanori Takenobu
, et al.
·
Cancer Science
·
10
Up-regulated expression of the uridine phosphorylase gene in human gastric tumors is correlated with a favorable prognosis.
2006
·
Kiyoko Kawamura
, Nobuhiro Takiguchi
, et al.
·
PubMed
·
10
The PRC2 molecule EED is a target of epigenetic therapy for neuroblastoma
2022
·
Dilibaerguli Shaliman
, Hisanori Takenobu
, et al.
·
European Journal of Cell Biology
·
9
CFC1 is a cancer stemness-regulating factor in neuroblastoma
2017
·
Koji Chikaraishi
, Hisanori Takenobu
, et al.
·
Oncotarget
·
9
PDF
HDM2 impairs Noxa transcription and affects apoptotic cell death in a p53/p73-dependent manner in neuroblastoma
2010
·
Yun Shi
, Hisanori Takenobu
, et al.
·
European Journal of Cancer
·
9
Polycomb group protein BMI1 protects neuroblastoma cells against DNA damage-induced apoptotic cell death
2022
·
Nobuhiro Akita
, Ryu Okada
, et al.
·
Experimental Cell Research
·
8
PDF
Positive regulatory loop of platelet-derived growth factor DD-induced STAT3 activation is associated with poor prognosis in advanced urothelial carcinoma
2023
·
Kiyohiro Ando
, Ryo Kurashina
, et al.
·
Biochemical and Biophysical Research Communications
·
6
L3MBTL2 maintains MYCN ‐amplified neuroblastoma cell proliferation through silencing NRIP3 and BRME1 genes
2024
·
Ryu Okada
, Hisanori Takenobu
, et al.
·
Genes to Cells
·
4
PDF
Show more works
View as search
Works count:
36
Citation count:
847
H-index:
14
I10-index:
19
Year
Topic
Type